Latest filing published 13 Nov 2017 for Apellis Pharmaceuticals, Inc..
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
AJU IB Investment Co., Ltd.: trading record in brief
This profile gathers the share dealings of AJU IB Investment Co., Ltd. across 2 companies, led by Rein Therapeutics, Inc. and Apellis Pharmaceuticals, Inc. The record holds 4 filings, for trades running from 5 July 2017 to 13 November 2017.
On the market, this insider has only ever bought: 1 purchase, €330k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The record was last updated on 13 November 2017 with a transaction in Apellis Pharmaceuticals, Inc. The most recent open-market purchase was published on 7 July 2017, 3,412 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to AJU IB Investment Co., Ltd.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,292,062 sharesCommon StockSEC:0000899243-17-026036:0
- 443,973 sharesCommon StockSEC:0000899243-17-018090:0
- 48,656 sharesCommon StockSEC:0000899243-17-018090:1
- 24,929 shares@ US$15.00Common StockSEC:0000899243-17-018090:2Canonical exit: 3 Oct 2017 (T+90)
4 of 4 declarations
